Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.360
+0.050 (1.51%)
Feb 18, 2026, 10:38 AM EST - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $594.85 million as of February 18, 2026. Its market cap has increased by 66.50% in one year.
Market Cap
594.85M
Enterprise Value
490.84M
1-Year Change
66.50%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $594.85M, a decrease of -63.45%. That is a compound annual growth rate of -26.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 586.00M | -4.61% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 614.75M |
| SELLAS Life Sciences Group | 611.31M |
| MeiraGTx Holdings | 599.66M |
| ProKidney | 595.65M |
| LB Pharmaceuticals | 590.48M |
| CorMedix | 578.31M |
| Design Therapeutics | 573.63M |
| Forte Biosciences | 572.57M |